In mouse models of triple negative breast cancer (TNBC), restricted glycolysis inhibited the expression of tumor granulocyte colony stimulating factor (G-CSF) and granulocyte macrophage colony stimulating factor (GM-CSF), reducing MDSCs and enhancing anti-tumor immunotherapy. Here, CSF2 is linked to triple-negative breast carcinoma.